COVID 19 UPDATE
Last updated on June 1, 2020, John Hopkins Corona Virus Dashboard and Worldometer
Cases Worldwide
Cases in the U.S.
Cases in California
UPDATE
From the beginning of the COVID-19 pandemic, children were relatively untouched by the novel coronavirus. When infected, children often had few symptoms
unless an underlying condition compromised their health. It was believed children could have the disease without suffering from the symptoms. Children recently have been presenting with a
rare but potentially dangerous complication thought linked to the coronavirus and now identified in at least seven states and the Washington, D.C., area.
For the record, pediatric multi-system inflammatory syndrome or PIMS hasn’t been definitively linked with COVID-19. “The general thought is that most of these cases that have been reported so far were a consequence of a COVID-19 infection,” says William Schaffner, M.D., an infectious disease specialist and professor at the Vanderbilt University School of Medicine. Doctors indicate it is the result of increased awareness of the problem. Information regarding PIMS is still extremely limited due to the small numbers of cases compared with the staggering numbers of people affected by COVID-19. Pediatric specialists around the country, including those at Children’s Hospital Los Angeles, are focusing their efforts on determining whether more cases exist.
What is MIS-C?
MIS-C stands for multisystem inflammatory syndrome, formerly called pediatric inflammatory multisystem syndrome, or PIMS. It describes a health condition in children who have been infected with novel coronavirus, recovered and developed a immune response that results in significant levels of inflammation in organ systems and symptoms. Children who have MIS-C generally did not have obvious symptoms when infected with the coronavirus, such as a cough, and generally were healthy prior to developing MIS-C.
Experts at Children’s Hospital Los Angeles (CHLA) noticed an increase in the number of patients diagnosed with Kawasaki disease during the month of April compared to the previous two years. CHLA’s team began testing to determine if patients had antibodies demonstrating past COVID-19 infection.
By conducting serology testing for antibodies, Children’s Hospital Los Angeles had diagnosed three patients with MIS-C. Each child was initially believed to have Kawasaki disease and received treatment. Positive antibody testing of the patients, combined with symptoms consistent with other patients around the world and additional negative viral testing, led the CHLA team to diagnose these patients with MIS-C
Hospitals in the United Kingdom and New York City started reporting children with significant inflammation, toxic shock syndrome and symptoms of Kawasaki disease following infection with the novel coronavirus. There are still new things experts are learning about MIS-C that has hospitalized children in the U.S., with at least 120 children across New York State, as of May 18, 2020.
The symptoms are similar to pediatric inflammatory conditions such as Kawasaki disease, staphylococcal and streptococcal toxic shock syndromes, bacterial sepsis and macrophage activation syndromes.
can be life-threatening.
What are the symptoms of pediatric multi-system inflammatory syndrome or MIS-C?
Children previously infected with novel coronavirus, recovered from it and later experienced an immune response that results in significant levels of inflammation in organ systems. Many children affected did not display the common symptoms of COVID-19 and were seen as healthy prior to developing the illness. Symptoms vary depending on which organ system is affected, according to the New York Department of Public Health but, in general, these appear to be the main signs of pediatric multi-system inflammatory syndrome:
Some children have needed blood pressure support and several requiring mechanical ventilation, the New York Department of Public Health said.
Is MIS-C/PIMS contagious?
No, MIS-C/PIMS is not contagious. In order to have MIS-C/PIMS, a child must have had the infection previously. It is believed that, for one to have the antibodies for COVID-19, a patient must be past the contagious stage of the disease.
Treatment for MIS-C/PIMS at Children’s Hospital Los Angeles
Currently, the treatment for MIS-C is a similar protocol to what is used to treat Kawasaki disease. The goal is to reduce the inflammation to avoid long-term damage to arteries in the child’s body and heart. This is accomplished through transfusions of plasma, which reduces the body’s own immune response that is causing the inflammation.
When should you take your child to the doctor?
Symptoms of MIS-C vary right now, but if your child develops a rash, red eyes, a high fever, or abdominal pain, Dr. Schaffner says you should see your child’s pediatrician immediately. If you’re not sure, call anyway—your child’s doctor should be able to guide you from there.
YOUNG ADULTS
Young adults have felt comfortable going to spots with large crowds, as media reports highlighting data from China’s outbreak, indicated younger people were not as susceptible to the coronavirus as older age groups or people with underlying conditions. But, that hasn’t held true. Now, in several major American cities, young adults between 18 and 40, account for the largest group testing positive.
Attention was generally focused on their role in influencing the spread and community transmission rather than the severity of infection in children and young adults themselves," wrote Roberta L. DeBiasi, MD, chief of the division of pediatric infectious diseases at Children's National Hospital, Washington, and colleagues.
As of May 21, 2020
“It Was A Complete Shock”
Young adults are now coming to terms with a new reality driven by statistics showing they are not safe from the coronavirus. News reports, such as the 25-year-old dying from COVID-19 or the announcement by Texas public health officials that 44 college students tested positive after returning from a group spring break trip to Mexico. This reality drove home the point that they, too, were at risk.
A tracking poll released last week found that most of the nation had adjusted its behavior to slow the spread of the coronavirus.
A March 16, 2020, report from the Centers for Disease Control and Prevention (CDC) shows that as of March 16, 2020, 508 people were hospitalized for COVID-19 in the U.S. 38% were between 20 and 54 years old. Half ending up in intensive care were younger than 65.
In a study published in the Journal of Pediatrics, researchers reviewed data from 44 hospitalized and 133 non-hospitalized children and young adults infected with SARS-CoV-2. The study population ranged from 0.1 to 34 years of age, with a median of 10 years.
What can you do to protect yourself?
If you have a serious underlying medical condition:
For more information on steps you can take to protect yourself, see CDC’s How to Protect Yourself
The Immune System
White blood cells are the first line of defense! The immune system fights off disease causing microorganisms and engineers the healing process. The immune system is vital to fighting every assault on the body! Understanding the role the immune systems plays in overall health will provide you the ability to take responsibility for your own health. The responsibility of the immune system is to learn and identify those things that naturally belong in the body and those foreign or harmful.
The Best Immune Boosters
When taking probiotics for an immune boost, get one with a variety of Lactobacillus and Bifidobacterium strains and a high concentration of CFUs, colony forming units – this is the amount of live microorganisms that help to populate the gut.
ALWAYS CONSULT YOUR PERSONAL HEALTH CARE PROFESSIONAL